| 发明名称 |
ANTI-CANCER TREATMENTS WITH ANTI-EGFR ANTIBODIES HAVING A LOW FUCOSYLATION |
| 摘要 |
The present invention pertains to the field of cancer therapy using anti-cancer antibodies. The medical use of anti-EGFR antibodies having improved glycosylation characteristics, in particular a reduced fucosylation, is provided which show anti-cancer efficacy and an improved adverse side effect profile. |
| 申请公布号 |
CA2908819(A1) |
申请公布日期 |
2014.10.30 |
| 申请号 |
CA20142908819 |
申请日期 |
2014.04.22 |
| 申请人 |
GLYCOTOPE GMBH |
发明人 |
GOLETZ, STEFFEN;DANIELCZYK, ANTJE |
| 分类号 |
C07K16/28;A61K39/00 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
